Literature DB >> 30924925

Regulatory T cell features in chronic granulomatous disease.

A van de Geer1, E Cuadrado2, M C Slot2, R van Bruggen1, D Amsen2, T W Kuijpers2,3.   

Abstract

Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by mutations in any of the genes encoding the phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase system, responsible for the production of reactive oxygen species (ROS). CGD is marked by invasive bacterial and fungal infections and by autoinflammation/autoimmunity, of which the exact pathophysiology remains elusive. Contributing factors include decreased neutrophil apoptosis, impaired apoptotic neutrophil clearance, increased proinflammatory protein expression and reduced ROS-mediated inflammasome dampening. We have explored a fundamentally different potential mechanism: it has been reported that macrophage-mediated induction of regulatory T cells (Tregs ) depends on ROS production. We have investigated whether numerical or functional deficiencies exist in Tregs of CGD patients. As the prevalence of autoinflammation/autoimmunity differs between CGD subtypes, we have also investigated Tregs from gp91phox -, p47phox - and p40phox -deficient CGD patients separately. Results show that Treg numbers and suppressive capacities are not different in CGD patients compared to healthy controls, with the exception that in gp91phox -deficiency effector Treg (eTreg ) numbers are decreased. Expression of Treg markers CD25, inducible T cell co-stimulator (ICOS), Helios, cytotoxic T lymphocyte antigen 4 (CTLA-4) and glucocorticoid-induced tumor necrosis factor receptor (GITR) did not provide any clue for differences in Treg functionality or activation state. No correlation was seen between eTreg numbers and patients' clinical phenotype. To conclude, the only difference between Tregs from CGD patients and healthy controls is a decrease in circulating eTregs in gp91phox -deficiency. In terms of autoinflammation/autoimmunity, this group is the most affected. However, upon culture, patient-derived Tregs showed a normal phenotype and normal functional suppressor activity. No other findings pointed towards a role for Tregs in CGD-related autoinflammation/autoimmunity.
© 2019 British Society for Immunology.

Entities:  

Keywords:  chronic granulomatous disease; inflammation; regulatory T cell

Year:  2019        PMID: 30924925      PMCID: PMC6642867          DOI: 10.1111/cei.13300

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

Review 1.  Chronic granulomatous disease: overview and hematopoietic stem cell transplantation.

Authors:  Elizabeth M Kang; Betty E Marciano; SukSee DeRavin; Kol A Zarember; Steven M Holland; Harry L Malech
Journal:  J Allergy Clin Immunol       Date:  2011-04-17       Impact factor: 10.793

2.  Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.

Authors:  Marc Vocanson; Aurore Rozieres; Anca Hennino; Gaelle Poyet; Vincent Gaillard; Sarah Renaudineau; Amine Achachi; Josette Benetiere; Dominique Kaiserlian; Bertrand Dubois; Jean-François Nicolas
Journal:  J Allergy Clin Immunol       Date:  2010-07-10       Impact factor: 10.793

3.  Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species.

Authors:  Marina D Kraaij; Nigel D L Savage; Sandra W van der Kooij; Karin Koekkoek; Jun Wang; J Merlijn van den Berg; Tom H M Ottenhoff; Taco W Kuijpers; Rikard Holmdahl; Cees van Kooten; Kyra A Gelderman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-22       Impact factor: 11.205

4.  Abnormal apoptosis in chronic granulomatous disease and autoantibody production characteristic of lupus.

Authors:  A N Sanford; A R Suriano; D Herche; K Dietzmann; K E Sullivan
Journal:  Rheumatology (Oxford)       Date:  2005-10-25       Impact factor: 7.580

5.  Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease.

Authors:  Scott D Kobayashi; Jovanka M Voyich; Kevin R Braughton; Adeline R Whitney; William M Nauseef; Harry L Malech; Frank R DeLeo
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

6.  Asbestos-derived reactive oxygen species activate TGF-beta1.

Authors:  Derek A Pociask; Patricia J Sime; Arnold R Brody
Journal:  Lab Invest       Date:  2004-08       Impact factor: 5.662

Review 7.  Inflammatory manifestations in chronic granulomatous disease (CGD).

Authors:  S D Rosenzweig
Journal:  J Clin Immunol       Date:  2008-01-12       Impact factor: 8.317

8.  Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1.

Authors:  Nigel D L Savage; Tjitske de Boer; Kimberley V Walburg; Simone A Joosten; Krista van Meijgaarden; Annemiek Geluk; Tom H M Ottenhoff
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

9.  Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cells.

Authors:  Olga Efimova; Philippe Szankasi; Todd W Kelley
Journal:  PLoS One       Date:  2011-01-06       Impact factor: 3.240

Review 10.  Current concepts of hyperinflammation in chronic granulomatous disease.

Authors:  Nikolaus Rieber; Andreas Hector; Taco Kuijpers; Dirk Roos; Dominik Hartl
Journal:  Clin Dev Immunol       Date:  2011-07-25
View more
  7 in total

Review 1.  Autoimmunity in Primary Immunodeficiencies (PID).

Authors:  Grace T Padron; Vivian P Hernandez-Trujillo
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-01       Impact factor: 8.667

Review 2.  The role of redox system in metastasis formation.

Authors:  Chiara Cencioni; Valentina Comunanza; Emanuele Middonti; Edoardo Vallariello; Federico Bussolino
Journal:  Angiogenesis       Date:  2021-04-28       Impact factor: 10.658

Review 3.  Reactive Oxygen Species in Autoimmune Cells: Function, Differentiation, and Metabolism.

Authors:  Weiji Lin; Pan Shen; Yaqin Song; Ying Huang; Shenghao Tu
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

Review 4.  Beyond the Extra Respiration of Phagocytosis: NADPH Oxidase 2 in Adaptive Immunity and Inflammation.

Authors:  Paige M Mortimer; Stacey A Mc Intyre; David C Thomas
Journal:  Front Immunol       Date:  2021-09-01       Impact factor: 7.561

Review 5.  Targeting DCs for Tolerance Induction: Don't Lose Sight of the Neutrophils.

Authors:  Florianne M J Hafkamp; Tom Groot Kormelink; Esther C de Jong
Journal:  Front Immunol       Date:  2021-10-05       Impact factor: 7.561

6.  Analgesic, anti-inflammatory and acute oral toxicity profile of leaf and bark extracts of Albizia procera.

Authors:  Sangeetha Mani; Chamundeeswari Duraipandian; Saravana Babu Chidambaram
Journal:  BMC Complement Med Ther       Date:  2022-02-25

Review 7.  Neutrophil-T cell crosstalk in inflammatory bowel disease.

Authors:  Egle Kvedaraite
Journal:  Immunology       Date:  2021-07-20       Impact factor: 7.397

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.